tiprankstipranks
Trending News
More News >
Advertisement

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Neutral
11Bullish
2Neutral
9Bearish
Oscillators
Buy
5Bullish
2Neutral
3Bearish
Moving Averages
Neutral
6Bullish
0Neutral
6Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.10, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 21.22, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 20.85, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Sep 28, 2025, 04:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.72
20.90
20.90
21.08
21.08
21.26
21.26
Fibonacci
20.90
20.97
21.01
21.08
21.15
21.19
21.26

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Sep 28, 2025, 04:06 AM
Period
Simple
Exponential
MA5
21.26Sell
21.16Sell
MA10
21.34Sell
21.25Sell
MA20
21.29Sell
21.22Sell
MA50
20.85Buy
20.85Buy
MA100
20.18Buy
20.34Buy
MA200
19.58Buy
19.95Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 21.25, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 20.34, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 20.85, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 20.18, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 19.58, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Sep 28, 2025, 04:06 AM
Name
Value
Action
RSI (14)
45.21
Neutral
STOCH (9,6)
-13.34
Buy
STOCHRSI (14)
-6.28
Buy
MACD (12,26)
0.10
Buy
ADX (14)
20.68
Neutral
Williams %R
-99.57
Buy
CCI (14)
-118.45
Buy
ATR (14)
0.12
-
Ultimate Oscillator
14.73
Sell
ROC
-2.15
Sell
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 45.21, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 20.68, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is -118.45, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is -2.15, creating a Sell signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Hold.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 45.21, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.10, which suggests CURE is a Buy.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 21.26, which suggests CURE is a Sell.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 21.29, which suggests CURE is a Sell.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 20.85, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 19.58, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -99.57, which suggests CURE is a Buy.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is -118.45, which suggests CURE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement